Access & Impact

Our Exclusive Documentary

Access & Impact

To Us, It’s Personal: Viatris Colleagues Talk Access

Access & Impact

Now Available | Nasdaq Webinar: The Power of Partnership to Address Antimicrobial Resistance

Discover Viatris

Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China

Discover Viatris

Rajiv Malik to retire as President of Viatris effective April 1, 2024